Morrissette Kali, Hansen Stefan, Pavlis Michelle, Murray John C
Department of Dermatology, Duke University School of Medicine, Durham, USA.
Department of Dermatology, Duke University Medical Center, Durham, USA.
Cureus. 2024 Dec 23;16(12):e76267. doi: 10.7759/cureus.76267. eCollection 2024 Dec.
Folliculitis decalvans (FD) is a chronic inflammatory alopecia characterized by painful, scarring lesions and recurrent flares, often complicated by secondary bacterial infections. Despite the use of topical and systemic anti-inflammatory or antimicrobial therapies, FD remains challenging to manage, with limited therapeutic advancements. We report a case of recalcitrant FD in a man in his 40s who experienced significant symptom improvement and hair regrowth following the initiation of tirzepatide for weight management. This case highlights a previously unreported therapeutic benefit of tirzepatide in FD, potentially mediated through its anti-inflammatory and immunomodulatory effects. As glucagon-like peptide 1 (GLP-1) receptor agonists gain recognition for their efficacy in other inflammatory skin conditions, such as psoriasis and hidradenitis suppurativa, this case supports further exploration of their role in managing FD and other refractory dermatologic diseases.
脱发性毛囊炎(FD)是一种慢性炎症性脱发,其特征为疼痛性瘢痕性皮损和反复发作,常并发继发性细菌感染。尽管使用了局部和全身抗炎或抗菌疗法,但FD的治疗仍然具有挑战性,治疗进展有限。我们报告了一例40多岁男性的顽固性FD病例,该患者在开始使用替尔泊肽进行体重管理后,症状得到显著改善,头发也重新生长。该病例突出了替尔泊肽在FD中以前未报道的治疗益处,可能是通过其抗炎和免疫调节作用介导的。随着胰高血糖素样肽1(GLP-1)受体激动剂因其在其他炎症性皮肤病(如银屑病和化脓性汗腺炎)中的疗效而获得认可,该病例支持进一步探索它们在管理FD和其他难治性皮肤病中的作用。